Dr. Anna Semmelroth is a Glenview, Illinois based nurse practitioner. Active license number of Dr. Anna Semmelroth is 209030634 in Illinois. Her current practice location is 2100 Pfingsten Rd, Glenview. Patients can reach her at 847-657-5800. Dr. Anna Semmelroth is APN, FNP-BC and her NPI number (Unique professional ID assigned by NPPES) is 1700603081. Dr. Anna Semmelroth has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Dr. Anna Semmelroth speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1700603081
NPI Enumeration Date:
26 Sep, 2024
NPI Last Update On:
11 Oct, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Anna Semmelroth are as mentioned below.
License Number
Specialization
State
Status
209030634
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Anna Semmelroth 2650 Ridge Ave Ste 1223, Evanston, Illinois
Zip:
60201-1700
Phone Number:
815-621-1313
Fax Number:
847-733-5315
Patients can reach Dr. Anna Semmelroth at 2100 Pfingsten Rd, Glenview, Illinois or can call to book an appointment on 847-657-5800.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.